Dharmesh Kant, Head of Research at Chola Securities, said Sun Pharma’s all-cash acquisition of Organon could improve return ratios and support valuations, but may...
Sun Pharmaceutical Industries Ltd. is close to finalising a deal to acquire assets of Organon, with an announcement expected soon, sources familiar with the...
In a week packed with corporate developments and regulatory shifts, market participants are weighing the implications of Sun Pharmaceutical Industries' latest acquisition move, fresh...